NCT03160794View on ClinicalTrials.gov

Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 23, 2017

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Post Prostatectomy
Interventions
DIAGNOSTIC_TEST

[18F]DCFPyL PET/MRI scan

PET/MRI imaging using the radiotracer, \[18F\]DCFPyL

RADIATION

Stereotactic Ablative Radiotherapy

SABR as treatment for lesions identified using \[18F\]DCFPyL PET/MRI

Trial Locations (1)

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER